Recent Advances In Transcranial Magnetic Stimulation (TMS) for Mental Health Disorders: A Narrative Review
Fuente:
Zenodo
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Recurso digital |
| Lenguaje: | inglés |
| Publicado: |
Zenodo
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866901557993275392 |
|---|---|
| author | Ala, Oluwapelumi Adebayo Oladosu, Olajumoke Aishat |
| author_facet | Ala, Oluwapelumi Adebayo Oladosu, Olajumoke Aishat |
| contents | <p>Since its development in 1985, repetitive Transcranial Magnetic Stimulation (rTMS) has evolved from a novel<br>neuromodulation technique to an FDA-approved treatment for several psychiatric conditions. The paper explains<br>the basic principles of TMS, including its mechanism of action, stimulation parameters, and targeting methods. It details<br>the FDA-approved protocols for three primary indications: major depressive disorder (MDD), obsessive-compulsive<br>disorder (OCD), and smoking cessation. For MDD, multiple protocols targeting the left dorsolateral prefrontal cortex<br>have shown response rates of 38-49%. In OCD, targeting the dorsomedial prefrontal cortex and anterior cingulate<br>cortex has demonstrated a 45% response rate. For smoking cessation, stimulation of the prefrontal cortex and insula<br>has shown promising results in achieving continuous abstinence. The paper also discusses future trends in TMS<br>research and highlights challenges in implementing this technology in low-and-middle income countries like Nigeria,<br>where barriers include insufficient funding, limited mental health infrastructure, and high treatment costs. It concludes<br>that while rTMS offers promising opportunities for personalized treatment approaches, improved mental health<br>services and policy changes are needed to increase its accessibility.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_15160917 |
| institution | Zenodo |
| language | eng |
| publishDate | 2024 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Recent Advances In Transcranial Magnetic Stimulation (TMS) for Mental Health Disorders: A Narrative Review Ala, Oluwapelumi Adebayo Oladosu, Olajumoke Aishat Transcranial Magnetic Stimulation (TMS) Repetitive Transcranial Magnetic Stimulation (rTMS) Mental Health Disorders Major Depressive Disorder (MDD) Obsessive- Compulsive Disorder (OCD) Smoking Cessation Neuromodulation <p>Since its development in 1985, repetitive Transcranial Magnetic Stimulation (rTMS) has evolved from a novel<br>neuromodulation technique to an FDA-approved treatment for several psychiatric conditions. The paper explains<br>the basic principles of TMS, including its mechanism of action, stimulation parameters, and targeting methods. It details<br>the FDA-approved protocols for three primary indications: major depressive disorder (MDD), obsessive-compulsive<br>disorder (OCD), and smoking cessation. For MDD, multiple protocols targeting the left dorsolateral prefrontal cortex<br>have shown response rates of 38-49%. In OCD, targeting the dorsomedial prefrontal cortex and anterior cingulate<br>cortex has demonstrated a 45% response rate. For smoking cessation, stimulation of the prefrontal cortex and insula<br>has shown promising results in achieving continuous abstinence. The paper also discusses future trends in TMS<br>research and highlights challenges in implementing this technology in low-and-middle income countries like Nigeria,<br>where barriers include insufficient funding, limited mental health infrastructure, and high treatment costs. It concludes<br>that while rTMS offers promising opportunities for personalized treatment approaches, improved mental health<br>services and policy changes are needed to increase its accessibility.</p> |
| title | Recent Advances In Transcranial Magnetic Stimulation (TMS) for Mental Health Disorders: A Narrative Review |
| topic | Transcranial Magnetic Stimulation (TMS) Repetitive Transcranial Magnetic Stimulation (rTMS) Mental Health Disorders Major Depressive Disorder (MDD) Obsessive- Compulsive Disorder (OCD) Smoking Cessation Neuromodulation |
| url | https://doi.org/10.5281/zenodo.15160917 |